Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters

Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters

Androgen Receptor-Targeted Agents (ARTA) have dramatically changed the therapeutic landscape of metastatic Castration-Resistant Prostate Cancer (mCRPC), but 20–40% of these patients progress early after start of ARTA treatment. The present study investigated the potential utility of plasma cell-free...

Full description

Bibliographic Details
Main Authors: Evgeniya Sharova, Marco Maruzzo, Paola Del Bianco, Ilaria Cavallari, Francesco Pierantoni, Umberto Basso, Vincenzo Ciminale, Vittorina Zagonel
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
mCRPC
cfmiRNA
abiraterone
enzalutamide
OS
PFS
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.626104/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.626104/full

Similar Items